What does this research mean for the field?

In clinical practice, patients with diabetes are not treated with the same intensity of vascular risk-reduction therapies as patients with a history of myocardial infarction, despite guidelines recommending they be treated as a coronary artery disease risk equivalent. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

January 26, 2007Open Access

Diabetes Is Not Treated as a Coronary Artery Disease Risk Equivalent

BSBaiju R. ShahOntario Institute for Cancer Research JHJanet E. HuxNorthwestern University PAPeter C. AustinHeart Failure & Transplant

PICO estructurado

Población

Patients newly diagnosed with diabetes and those with first myocardial infarction

The text discusses whether diabetes is treated as a coronary artery disease risk equivalent in clinical practice, as recommended by guidelines.

Resumen

O bservational studies (1–3) havesuggested that the risk of mortalityis equivalent for patients with myo-cardial infarction (MI) without previous diabetes and for diabetic patients without previous MI. Because vascular risk-reduction targets are based on a patient’s future risk, clinical practice guidelines (4–9) recommend that the same or lower blood pressure and lipid targets be ap-plied to diabetic patients as would be ap-plied for secondary prevention following MI. Patients newly diagnosed with diabe-tes and those with first MIs enter a high-risk category for subsequent coronary events. Therefore, if diabetes were treated as a coronary artery disease risk equiva-

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo